Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002230758 | SCV000543505 | uncertain significance | HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED | 2021-12-15 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 132 of the CBS protein (p.Arg132His). This variant is present in population databases (rs779011920, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with CBS-related conditions. ClinVar contains an entry for this variant (Variation ID: 405373). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV000462847 | SCV001781423 | uncertain significance | Classic homocystinuria | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002261087 | SCV002541702 | uncertain significance | not provided | 2021-05-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000462847 | SCV002083818 | uncertain significance | Classic homocystinuria | 2020-08-25 | no assertion criteria provided | clinical testing |